Inside Health Policy, Inside Drug Pricing | FDA Lays Out Detailed Plan for Conducting Remote Facility Inspections

Cathy Burgess and Natalie Clayton are quoted on the backlogs of onsite facility inspections by the U.S. Food and Drug Administration and how the delays put generic drug applications at risk.

Cathy Burgess is quoted on how the Food and Drug Administration might conduct remote inspections of drug manufacturing facilities amid COVID-19.

This week, CMS finalized rules on minimum nursing home staffing standards, as well as access and quality standards in Medicaid, and the Federal Trade Commission (FTC) banned private employers from utilizing most noncompete clauses in employee contracts.

This week, CMS released the FY2025 Hospital Inpatient Prospective Payment System (IPPS) and Long-Term Care Hospital Prospective Payment System (LTCH PPS) Proposed Rule, and Congress held hearings on chronic care and telehealth proposals.

This week, members of the House of Representatives elected Representative Mike Johnson (R-LA-4) as the new Speaker and the Health Resources and Services Administration (HRSA) issued a notice of registration requirements for off-site, outpatient hospital facilities to participate in the 340B Drug Pricing Program.